Activaero America, Inc.

Activaero is the world leader in controlled breathing technologies for inhaled therapeutic agents. With stand alone inhalation products and inhalation systems available for clinical trials and marketing partnerships, Activaero's technologies allow for the most precise and efficient patient-tailored pulmonary delivery. Activaero currently has two products on the market, AKITA(R), a patient-tailored controlled breathing system with a smartcard that records the patient dosing parameters, and Watchhaler(TM), a hand held delivery system tailored specifically to children. The Company also has available a range of technologies ideal for the controlled delivery of inhaled therapeutics in the clinical trial setting and tailored to specific partnerships (AKITA2(R), LimiX(TM). Finally, Activaero works with partners on a consultancy basis in the development of ideal inhaled delivery systems and the logistics in clinical trials. Activaero's technological approach has been validated repeatedly in the clinical setting. The Company is privately held and located in GemA 1/4nden (Wohra) and Munich in Germany and Dublin, Ohio in the USA.